Email this article to a friend
Designing a HER2/neu promoter to drive α1,3galactosyltransferase expression for targeted anti-αGal antibody-mediated tumor cell killing
-
* Corresponding author: Jean-Claude Lefebvre lefebvre@unice.fr
Breast Cancer Research 2005, 7:R487-R494 doi:10.1186/bcr1034